Tickerplace logo

Tickerplace

BioCardia, Inc. logo

BCDABioCardia, Inc.

BCDA Stock Price, Valuation & Chart | BioCardia, Inc.

Compare
$1.110+0.01 (+0.91%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyBCDA intrinsic valueBCDA calculated fair value vs price
OverviewFinancialsDividendsRatios

BCDA Historical price chart

BCDA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization16.52M
PE Ratio-1.22
EPS-0.91
Trading Volume50.74K
Today's High/Low1.13/1.1
Dividend Yield0.00
52 Week High/Low2.29/0.75
Shares Outstanding14.88M
BCDA Financial Statement
BCDA Analyst ratings
BCDA Analysis & performance metrics

BCDA Company profile

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead…

BCDA Management team

Management
Edward M. Gillis
Senior Vice President of Devices
David McClungCFO
Chief Financial Officer
Peter A. Altman Ph.D.CEO
Chief Executive Officer, President & Director
Total 3 executives

BCDA Frequently asked questions

What is BioCardia, Inc. (BCDA) Stock Price?

Current stock price of BioCardia, Inc. (BCDA) stock is $1.110. The stock price is +0.91% higher in the session. The intraday range can be seen from this page. Volume of BioCardia, Inc. (BCDA) stock is 50.74K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the BioCardia, Inc. (BCDA) stock price going up or down today?

The stock price of BioCardia, Inc. (BCDA) can change with earnings, company news, and overall market sentiment. BioCardia, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioCardia, Inc. stock expensive at its current price?

Whether BioCardia, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BCDA on this page is -1.22. EPS on this page is -0.91. Compare those figures with peers and growth expectations before deciding if the current BioCardia, Inc. price is justified.

How has the stock price of BioCardia, Inc. (BCDA) performed historically?

Historical performance for BioCardia, Inc. (BCDA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BCDA reacted to past earnings and market events.

Should I buy BioCardia, Inc. (BCDA) stock, at this price?

Buying BioCardia, Inc. (BCDA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.